Neurocrine Biosciences In... (NBIX)
112.64
-1.36 (-1.19%)
At close: Mar 28, 2025, 11:21 AM
Neurocrine Biosciences Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 | FY98 | FY97 | FY96 |
| Revenue | 2.36B | 1.89B | 1.49B | 1.13B | 1.05B | 788.1M | 451.24M | 161.63M | 15M | 19.77M | n/a | 2.92M | 53.14M | 77.41M | 33.5M | 2.95M | 3.98M | 1.22M | 39.23M | 123.89M | 85.18M | 139.08M | 18.05M | 41.24M | 14.59M | 16.8M | 16M | 26.1M | 19.2M |
| Cost of Revenue | 34M | 39.7M | 23.2M | 14.3M | 10.1M | 7.4M | 4.89M | 1.25M | 35.9M | 33.8M | 14.4M | 13.8M | 11.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.2M | -2.1M | -1.7M | -1.3M | -1M |
| Gross Profit | 2.32B | 1.85B | 1.47B | 1.12B | 1.04B | 780.7M | 446.35M | 160.37M | -20.9M | -14.03M | -14.4M | -10.88M | 41.54M | 77.41M | 33.5M | 2.95M | 3.98M | 1.22M | 39.23M | 123.89M | 85.18M | 139.08M | 18.05M | 41.24M | 16.79M | 18.9M | 17.7M | 27.4M | 20.2M |
| Operating Income | 570.5M | 250.9M | 249M | 196.9M | 318.9M | 219.15M | 36.9M | -131.36M | -147.37M | -94.2M | -64.41M | -49.68M | 1.45M | 33.92M | -13.72M | -53.67M | -87.3M | -212.24M | -113.32M | -25.07M | -52.33M | -58.79M | -103.61M | -43.88M | -35.6M | -19.9M | -12.4M | 500K | 2.9M |
| Interest Income | 91M | n/a | 11.2M | 3.8M | 12.6M | 19.21M | n/a | n/a | 2.84M | 1.93M | 629K | 400K | 489K | 435K | 397K | 691K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | 486M | 332.1M | 213.9M | 101.4M | 106.7M | 46.5M | 21.84M | -142.54M | -141.09M | -88.93M | -60.54M | -46.09M | 5.03M | 37.57M | -7.97M | -88.61M | -88.61M | -207.3M | -107.2M | -22.19M | -45.69M | -30.1M | -94.54M | -36.79M | -28.51M | -19.7M | -19.8M | 5.3M | 6.1M |
| Net Income | 341.3M | 249.7M | 154.5M | 89.6M | 407.3M | 37M | 21.11M | -142.54M | -141.09M | -88.93M | -60.54M | -46.09M | 5.03M | 37.57M | -7.97M | -51.04M | -88.61M | -207.3M | -107.2M | -22.19M | -45.77M | -30.26M | -94.54M | -36.91M | -28.81M | -16.8M | -20M | 5.1M | 5.9M |
| Selling & General & Admin | 1.01B | 887.6M | 752.7M | 583.3M | 433.3M | 354.1M | 248.93M | 169.91M | 68.08M | 32.48M | 17.99M | 13.35M | 13.44M | 12.46M | 16.07M | 14.83M | 20.24M | 37.48M | 54.87M | 42.33M | 22.44M | 20.59M | 12.72M | 10.86M | 9.96M | 7.5M | 6.6M | 5.7M | 3.7M |
| Research & Development | 731.1M | 565M | 463.8M | 328.1M | 275M | 200M | 160.52M | 121.83M | 94.29M | 81.49M | 46.42M | 39.25M | 37.16M | 30.95M | 31.15M | 35.81M | 55.29M | 81.98M | 97.68M | 106.63M | 115.07M | 177.27M | 108.94M | 74.27M | 40.23M | 29.2M | 21.8M | 19.9M | 12.6M |
| Other Expenses | 12.5M | 143.9M | n/a | 105.3M | 164.5M | 154.27M | n/a | -20K | 13K | 11K | 18K | 16K | 14K | 42.23M | 73.29M | 70.99M | 15.74M | 94M | 90.96M | 97.44M | 87.91M | 80.57M | 96.58M | n/a | 2.2M | 2.1M | 1.7M | 1.3M | 1M |
| Operating Expenses | 1.75B | 1.6B | 1.22B | 911.4M | 708.3M | 554.1M | 409.46M | 291.73M | 162.37M | 113.97M | 64.41M | 52.6M | 51.69M | 43.41M | 47.22M | 50.64M | 91.27M | 213.47M | 152.55M | 148.96M | 137.51M | 197.87M | 121.66M | 85.12M | 52.39M | 38.8M | 30.1M | 26.9M | 17.3M |
| Interest Expense | n/a | 4.6M | 7.1M | 25.8M | 32.8M | 32M | 30.53M | 19.52M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.03M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -82K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 1.78B | 1.64B | 1.24B | 925.7M | 718.4M | 561.5M | 414.35M | 292.99M | 162.37M | 113.97M | 64.41M | 52.6M | 51.69M | 43.41M | 47.22M | 50.64M | 91.27M | 213.47M | 152.55M | 148.96M | 137.51M | 197.87M | 121.66M | 85.12M | 50.19M | 36.7M | 28.4M | 25.6M | 16.3M |
| Income Tax | 144.7M | 82.4M | 59.4M | 11.8M | -300.6M | 9.5M | 730K | 17.1M | -7.72M | -6.27M | -4.68M | -4.24M | -4.22M | -4.26M | n/a | 173K | 1.31M | -4.94M | n/a | n/a | 79K | 158K | -9.08M | 120K | 302K | -3.1M | 7.6M | 200K | 200K |
| Shares Outstanding (Basic) | 100.4M | 97.7M | 95.8M | 94.6M | 93.1M | 91.63M | 95.4M | 87.99M | 86.56M | 84.5M | 74.58M | 66.8M | 65.62M | 55.18M | 52.82M | 39.14M | 38.45M | 38.01M | 37.72M | 36.76M | 36.2M | 32.37M | 30.49M | 26.03M | 22.12M | 19.07M | 18.14M | 17M | 15.13M |
| Shares Outstanding (Diluted) | 103.7M | 101M | 98.9M | 97.9M | 97.8M | 95.73M | 95.4M | 88.09M | 86.71M | 84.5M | 74.58M | 66.99M | 66.95M | 56.35M | 52.82M | 39.14M | 38.45M | 38.01M | 37.72M | 37.99M | 36.2M | 32.37M | 30.49M | 26.03M | 22.12M | 19.07M | 18.14M | 18.21M | 16.39M |
| EPS (Basic) | 3.40 | 2.56 | 1.61 | 0.95 | 4.37 | 0.40 | 0.22 | -1.62 | -1.63 | -1.05 | -0.81 | -0.69 | 0.08 | 0.68 | -0.15 | -1.3 | -2.3 | -5.45 | -2.84 | -0.6 | -1.26 | -0.93 | -3.1 | -1.42 | -1.3 | -0.88 | -1.1 | 0.30 | 0.39 |
| EPS (Diluted) | 3.29 | 2.47 | 1.56 | 0.92 | 4.16 | 0.39 | 0.22 | -1.62 | -1.63 | -1.05 | -0.81 | -0.69 | 0.08 | 0.67 | -0.15 | -1.3 | -2.3 | -5.45 | -2.84 | -0.58 | -1.26 | -0.93 | -3.1 | -1.42 | -1.3 | -0.88 | -1.1 | 0.28 | 0.36 |
| EBITDA | 610.1M | 358M | 264.6M | 218.7M | 336.1M | 226.6M | 56.4M | -120.62M | -139.59M | -87.92M | -63.58M | -49.01M | 2.1M | 34.62M | -13.72M | -47.86M | -73.98M | -193.97M | -102.75M | -14.98M | -45.25M | -55.09M | -100.52M | -41.23M | -33.4M | -17.8M | -10.7M | 1.8M | 3.9M |
| Depreciation & Amortization | 27.1M | 21.3M | 15.6M | 10.9M | 8.6M | 7.45M | 4.02M | 2.4M | 1.5M | 1.01M | 827K | 671K | 657K | 694K | 1.44M | 3.18M | 7.61M | 9.4M | 10.57M | 10.09M | 7.08M | 3.69M | 3.1M | 2.65M | 2.2M | 2.1M | 1.7M | 1.3M | 1M |